SART3 |
KPNA2 |
||
---|---|---|---|
Gene Name | squamous cell carcinoma antigen recognized by T cells 3 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | |
Image | |||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 12 interactors: AR C6 COIL HIST2H2AC HIST2H2BE KPNA2 LSM7 MEGF10 PRPF3 RNPS1 USP15 USP4 | 104 interactors: ACTN1 ACTN4 ANKIB1 AP2B1 APOBEC1 APP ARL4A ARL5A BRCA1 BTBD2 CASP2 CCDC107 CDA CDK5RAP3 CHD3 CHEK2 CORO1B CREB3L3 CREBBP CSE1L CSNK1A1 CUL4B DCTN2 DDIT3 EP300 EPB41 FEZ2 FN1 FTH1 GART GMCL1 GRB2 H1F0 HAP1 HMG20A HNRNPC HOMER2 HOMEZ HSPA4 IFT20 IMMT INO80E ITK JUN KLC4 KPNB1 KRT18 KRT40 KRT8 LAMB2 LEF1 LZTS2 MAGED1 MAGEH1 MDFI MLH1 MORC3 MVP MYC NECAB2 NFKBIB NMNAT1 NR3C1 NUP153 NUP50 NUP62 NUTM1 PAX5 PLAG1 PNMA5 PRKD3 PTMA RAG1 RAN RANBP2 RBM48 RBPMS RECQL RELA RELB RGL2 RILP RNMT SART3 SERTAD3 SGK1 SLC2A2 SPRY1 SRPK1 TADA2A TAF3 TAF8 TANK TBPL2 TP53 TRAF1 TRIM54 TSC22D4 TXNIP UBR5 USHBP1 ZBTB7B ZC3H12A ZNF131 | |
Entrez ID | 9733 | 3838 | |
HPRD ID | 11532 | 02818 | |
Ensembl ID | ENSG00000075856 | ENSG00000182481 | |
Uniprot IDs | B7ZKM0 Q15020 | P52292 Q7Z726 | |
PDB IDs | 2DO4 | 1EFX 1QGK 1QGR 3FEX 3FEY 4E4V | |
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | a24
alleles
antigen
antigens
attempted
bc
cd8
ctls
efficiently
enhancer
epitope
ezh2735
hla
homolog
igg
immunotherapy
leukocyte
mononuclear
mrp3
mrp31293
multidrug
panel
peptides
polycomb
reactive
rejection
thereafter
zeste
|
aggressive
aggressiveness
assembled
attempt
carcinomas
curable
diagnostics
disregarding
eic
emgd
endometrial
entities
figo
immunoreactivity
interplay
introducing
malignancy
mediator
mfe
microarrays
nucleocytoplasmic
precancerous
regimens
surgically
tmas
trp53
tumour
untreatable
uterus
|
|
Tagcloud (Difference) ? | a24
alleles
antigen
antigens
attempted
bc
cd8
ctls
efficiently
enhancer
epitope
ezh2735
hla
homolog
igg
immunotherapy
leukocyte
mononuclear
mrp3
mrp31293
multidrug
panel
peptides
polycomb
reactive
rejection
thereafter
zeste
|
aggressive
aggressiveness
assembled
attempt
carcinomas
curable
diagnostics
disregarding
eic
emgd
endometrial
entities
figo
immunoreactivity
interplay
introducing
malignancy
mediator
mfe
microarrays
nucleocytoplasmic
precancerous
regimens
surgically
tmas
trp53
tumour
untreatable
uterus
|
|
Tagcloud (Intersection) ? |